Weight-loss medications are associated with an increased risk of preterm birth in women with pre-existing diabetes

UVA researcher receives $3.4 million grant to improve weight management programs

Weight-loss medications have been associated with an increased risk of preterm birth among women who took them before pregnancy or during early pregnancy to treat preexisting diabetes. However, a large study of more than 750,000 pregnancies found that weight loss medication use was not associated with preterm birth or other birth complications. study authors, in … Read more

Understanding and navigating weight loss medications

Understanding and navigating weight loss medications

Stuff on the game-changing GLP-1 and semaglutide weight loss drugs, and 6 steps to a healthy approach to weight loss and management. In a world where we are bombarded with social media influencers and celebrities offering their experiences, thoughts, and unsolicited advice to a large audience, there is no substitute for sound medical advice and … Read more

What happens when patients stop taking GLP-1 medications? A new Cleveland Clinic study reveals real-world insights

Gray gradient

As the use of injectable GLP-1 drugs continues to increase, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 patients suggests that, on average, ceasing semaglutide and terzapatide does not lead to significant weight regain in clinical practice, as many patients later resume … Read more